Literature DB >> 15225226

Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.

S Tsiodras1, R Zafiropoulou, J Giotakis, G Imbrios, A Antoniades, E K Manesis.   

Abstract

We describe the rare case of a diabetic patient who was successfully treated for cytomegalovirus viremia and leishmaniasis following liver transplantation for hepatitis C virus-related cirrhosis, but also developed invasive sinus Aspergillus infection, while still on liposomal amphotericin B (AmBisome). The patient refused radical surgery including eye enucleation, and received a combination of intravenous caspofungin and voriconazole, along with repeated, conservative, local surgical debridement. At follow-up, 15 months after the onset of sinusitis, the patient remains culture-negative, fully active, and without evidence of local recurrence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225226     DOI: 10.1111/j.1399-3062.2004.00039.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  2 in total

1.  Are systemic voriconazole and caspofungin ototoxic? An experimental study with rats.

Authors:  Emine Aydın; Filiz Aydoğan; Eren Taştan; Ayşe Iriz; Gökhan Karaca; Ilknur Haberal Can
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-08-27       Impact factor: 3.372

Review 2.  Fungal Infections in Liver Transplant Recipients.

Authors:  Michael Scolarici; Margaret Jorgenson; Christopher Saddler; Jeannina Smith
Journal:  J Fungi (Basel)       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.